| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.2 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |